Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIGD1AP12 (HIG1 hypoxia inducible domain family member 1A pseudogene 12) is classified as a pseudogene in humans and does not encode a functional protein. It is not involved in any characterized molecular pathway, has no known biological function, and is distinct from the protein-coding gene HIGD1A, which is involved in mitochondrial homeostasis and stress response. As a pseudogene, HIGD1AP12 does not serve as a therapeutic target, biomarker, or have any direct disease associations[1][2][6]. Clarification: The query refers to a pseudogene ("HIGD1AP12"), not a protein-coding gene or functional therapeutic target. If you intended information on the functional gene or its protein product (HIGD1A), please specify, as HIGD1A is a distinct, protein-coding, functionally relevant gene and target[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 12 (HIGD1AP12).